Amphastar Pharmaceuticals
AMPH
AMPH
222 hedge funds and large institutions have $1.06B invested in Amphastar Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $1.07B → $1.06B (-$7.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
90% less call options, than puts
Call options by funds: $6.06M | Put options by funds: $60.7M
Holders
222
Holding in Top 10
2
Calls
$6.06M
Puts
$60.7M
Top Buyers
| 1 | +$9.56M | |
| 2 | +$9.2M | |
| 3 | +$7.62M | |
| 4 |
Goldman Sachs
New York
|
+$7.42M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$6.7M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$7.79M | |
| 3 | -$7.11M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.83M |
| 5 |
PCM
Penserra Capital Management
Orinda,
California
|
-$6.42M |